The Company has received the proceeds of USD I
Bonds Tranche III amounting to US$20 million on 1
August 2012.
As stated in the Prospectus, the Company will utilize
the net proceeds of Medco USD Bonds III to finance
capital expenditure amounting to 100% of the net
proceeds or equal to US$19.88 million of the net
proceeds. AS of 14 April 2014, a total of US$19.88
million from the net proceeds of said offering was
used by the Company for capital expenditure.